• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌炎中的免疫细胞调节因子与效应机制

Immunological cellular regulator and effector mechanisms in myocarditis.

作者信息

Maisch B, Bülowius U, Schmier K, Klopf D, Koper D, Sibelis T, Kochsiek K

出版信息

Herz. 1985 Feb;10(1):8-14.

PMID:2858443
Abstract

The diagnosis, pathogenesis and etiology of myocarditis are often difficult to establish with certainty. Consequently, we investigated cellular regulator and effector mechanisms in patients with viral heart disease (Coxsackie B3, influenza, EBV, mumps) as well as other inflammatory heart diseases which could not be classified etiologically. In acute myocarditis there was an elevation of B- and activated T-lymphocytes (OKIa 1-positive) but, in contrast, no significant changes in the activity of peripheral suppressor T-cells (OKT 8-positive). The activity of cell-specific lymphocytic effector mechanisms against vital cardiocytes was unchanged or slightly elevated in myocarditis, while the activity of the less target cell specific natural killer cells, which were measured in vitro against K562 tumor cells, was diminished. These findings are indicative of increased activity of target specific cytotoxic effector mechanisms and a reduction in the activity of nonspecific cellular effector mechanisms in peripheral blood.

摘要

心肌炎的诊断、发病机制和病因往往难以确切确定。因此,我们研究了病毒性心脏病(柯萨奇B3病毒、流感病毒、EB病毒、腮腺炎病毒)患者以及其他病因无法分类的炎症性心脏病患者的细胞调节和效应机制。在急性心肌炎中,B淋巴细胞和活化的T淋巴细胞(OKIa 1阳性)有所升高,但相比之下,外周抑制性T细胞(OKT 8阳性)的活性没有显著变化。在心肌炎中,针对重要心肌细胞的细胞特异性淋巴细胞效应机制的活性未改变或略有升高,而在体外针对K562肿瘤细胞测定的对靶细胞特异性较低的自然杀伤细胞的活性则降低。这些发现表明外周血中靶标特异性细胞毒性效应机制的活性增加,而非特异性细胞效应机制的活性降低。

相似文献

1
Immunological cellular regulator and effector mechanisms in myocarditis.心肌炎中的免疫细胞调节因子与效应机制
Herz. 1985 Feb;10(1):8-14.
2
[Dilated cardiomyopathy. An analysis of the viral-immunological theory].[扩张型心肌病。病毒免疫理论分析]
Ter Arkh. 1985;57(4):136-40.
3
Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis.心肌炎和心包心肌炎中的免疫调节及效应机制。
Heart Vessels Suppl. 1985;1:209-17. doi: 10.1007/BF02072395.
4
Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy.急性心肌炎和扩张型心肌病患者心脏中浸润细胞内T细胞受体Vα-Vβ基因的限制性使用
J Clin Invest. 1995 Aug;96(2):1035-41. doi: 10.1172/JCI118089.
5
[Secondary immunopathogenesis in myocarditis, diseases of the heart muscles and infarct-associated arrhythmia in childhood and adulthood].[儿童及成人心肌炎、心肌疾病和梗死相关心律失常中的继发性免疫发病机制]
Wien Klin Wochenschr. 1989 Jan 6;101(1):31-9.
6
Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.前列腺素E2治疗小鼠免疫复合物性肾小球肾炎所诱导的体液免疫和细胞免疫的系列变化
J Lab Clin Med. 1985 Nov;106(5):517-23.
7
Inflammatory dilated cardiomyopathy (DCMI).炎症性扩张型心肌病(DCMI)。
Herz. 2005 Sep;30(6):535-44. doi: 10.1007/s00059-005-2730-5.
8
[Characteristics of immunoregulatory lymphocyte subpopulations in patients with congestive cardiomyopathy and nonrheumatic myocarditis studied by monoclonal antibodies].
Ter Arkh. 1984;56(10):56-8.
9
T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.T 细胞转录因子 T-bet 通过抑制白细胞介素 17 的局部产生对自身免疫性心肌炎起负向调节作用。
J Exp Med. 2006 Aug 7;203(8):2009-19. doi: 10.1084/jem.20052222. Epub 2006 Jul 31.
10
CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.细胞毒性T淋巴细胞相关蛋白4(CTLA-4)缺失与白细胞介素-12驱动的分化协同增强细胞毒性T淋巴细胞的心脏致病性。
Circ Res. 2007 Aug 3;101(3):248-57. doi: 10.1161/CIRCRESAHA.106.147124. Epub 2007 Jun 14.

引用本文的文献

1
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.心肌炎的标准和病因导向的循证治疗:现状和未来展望。
Heart Fail Rev. 2013 Nov;18(6):761-95. doi: 10.1007/s10741-012-9362-7.
2
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.(围)心肌炎和炎症性心肌病的当前治疗选择。
Herz. 2012 Sep;37(6):644-56. doi: 10.1007/s00059-012-3679-9.
3
Epstein-Barr virus myocarditis as a cause of sudden death: two autopsy cases.爱泼斯坦-巴尔病毒心肌炎作为猝死原因:两例尸检病例
Int J Legal Med. 2005 Jul;119(4):231-5. doi: 10.1007/s00414-005-0540-1. Epub 2005 Apr 9.
4
Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis.载脂蛋白J/簇集素可限制小鼠自身免疫性心肌炎的严重程度。
J Clin Invest. 2000 Nov;106(9):1105-13. doi: 10.1172/JCI9037.
5
Four years of experience in endomyocardial biopsy--an immunohistologic approach.
Heart Vessels Suppl. 1985;1:59-67. doi: 10.1007/BF02072363.
6
Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.柯萨奇病毒B3诱导的心肌炎。在BALB/c小鼠中,自身免疫不依赖L3T4⁺辅助性T细胞和白细胞介素-2。
Am J Pathol. 1987 May;127(2):335-41.
7
Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment.柯萨奇病毒B-3心肌炎。针对心脏抗原的T细胞自身免疫对环孢素A治疗有抗性。
Am J Pathol. 1986 Nov;125(2):244-51.
8
Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.柯萨奇病毒B-3心肌炎。DBA/2和Balb/c小鼠不同致病机制的鉴定。
Am J Pathol. 1986 Feb;122(2):284-91.